Indole-3-Acetamido-Polyamines as Antimicrobial Agents and Antibiotic Adjuvants

Biomolecules. 2023 Aug 7;13(8):1226. doi: 10.3390/biom13081226.

Abstract

The widespread incidence of antimicrobial resistance necessitates the discovery of new classes of antimicrobials as well as adjuvant molecules that can restore the action of ineffective antibiotics. Herein, we report the synthesis of a new class of indole-3-acetamido-polyamine conjugates that were evaluated for antimicrobial activities against a panel of bacteria and two fungi, and for the ability to enhance the action of doxycycline against Pseudomonas aeruginosa and erythromycin against Escherichia coli. Compounds 14b, 15b, 17c, 18a, 18b, 18d, 19b, 19e, 20c and 20d exhibited strong growth inhibition of methicillin-resistant Staphylococcus aureus (MRSA) and Cryptococcus neoformans, with minimum inhibitory concentrations (MIC) typically less than 0.2 µM. Four analogues, including a 5-bromo 15c and three 5-methoxyls 16d-f, also exhibited intrinsic activity towards E. coli. Antibiotic kill curve analysis of 15c identified it to be a bactericide. While only one derivative was found to (weakly) enhance the action of erythromycin against E. coli, three examples, including 15c, were found to be strong enhancers of the antibiotic action of doxycycline against P. aeruginosa. Collectively, these results highlight the promising potential of α,ω-disubstituted indole-3-acetamido polyamine conjugates as antimicrobials and antibiotic adjuvants.

Keywords: antibiotics; antifungal agents; antimicrobial; indole-3-acetamide; polyamine; potentiator; structure-activity relationships.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic
  • Adjuvants, Pharmaceutic
  • Anti-Bacterial Agents / pharmacology
  • Anti-Infective Agents*
  • Doxycycline
  • Erythromycin / pharmacology
  • Escherichia coli
  • Fatty Acids, Omega-3*
  • Indoles / pharmacology
  • Methicillin-Resistant Staphylococcus aureus*
  • Polyamines / pharmacology
  • Pseudomonas aeruginosa

Substances

  • Anti-Bacterial Agents
  • Doxycycline
  • Anti-Infective Agents
  • Adjuvants, Immunologic
  • Adjuvants, Pharmaceutic
  • Erythromycin
  • Fatty Acids, Omega-3
  • Indoles
  • Polyamines

Grants and funding

This research was funded by the Catalyst: Seeding Dumont d’Urville NZ-France Science & Technology Support Programme (19-UOA-057-DDU) provided by the New Zealand Ministry of Business, Innovation and Employment and administered by the Royal Society Te Apārangi.